Nearly 40% of women report low libido during their menopause transition. Yet only one treatment has consistent clinical evidence for addressing it: testosterone. Not the pellets promising eternal youth. Not the "optimization protocols" from wellness clinics. But pharmaceutical-grade, monitored, low-dose testosterone prescribed for a specific medical indication.
So can women take testosterone for symptoms related to menopause? Yes, and when used appropriately, it's safe. The key is understanding who should take it, how it should be dosed and monitored, and what realistic benefits and risks look like. This empowers you to make informed decisions about whether testosterone therapy is right for your situation.
Is testosterone safe for women in menopause and perimenopause?
Yes, when properly dosed and monitored. Short-term studies show reassuring safety data at physiologic female levels.
Should all menopausal women take testosterone?
No. It's only recommended for one specific symptom: persistent, distressing low sexual desire.
What are the real risks of testosterone therapy for women?
At appropriate doses, serious side effects are uncommon. Overdosing carries risks of irreversible changes.
How should women take testosterone safely during menopause?
Low-dose transdermal preparations with regular blood work and symptom monitoring.
Should I try supplements instead of hormone therapy?
Supplements can support general health but typically can't address true hormone deficiencies that cause significant symptoms.
What makes testosterone therapy unsafe for some women?
Certain medical histories, lack of monitoring, or using it for unproven indications increases risk.
Testosterone isn't just a "male hormone." Women produce it too, primarily from the ovaries and adrenal glands. It plays important roles in sexual desire and arousal, energy and motivation, mood and confidence, and bone and muscle health.
During menopause, testosterone levels decline gradually, unlike estrogen's sharp drop. For some women, this decline is clinically significant and contributes to bothersome symptoms. But here's an important distinction: having low testosterone doesn't automatically mean you need replacement therapy. The question isn't just "Are my levels low?" but "Will testosterone therapy address my specific menopause concerns, and is it the best approach for me?"
Women should consider testosterone therapy for menopause when they have Hypoactive Sexual Desire Disorder (HSDD): persistent, distressing low sexual desire that isn't explained by relationship problems, depression, medications, or other untreated menopause symptoms.
Multiple randomized controlled trials show that for this specific group of women, low-dose testosterone:
This recommendation is endorsed by the International Society for the Study of Women's Sexual Health and major menopause societies globally. Recent 2026 guidelines reaffirm this position.
Even though testosterone is mainly recommended for low sexual desire that causes distress, some clinicians also see improvements in energy, mood, focus, sleep, or overall wellbeing in certain women with low testosterone. These effects aren’t guaranteed and usually depend on careful testing, ruling out other causes, and close follow-up. Testosterone shouldn’t be started for these reasons alone, but they can be part of the bigger picture when treatment is done thoughtfully.
Let's address the central concern directly: when used appropriately, testosterone therapy is safe for menopausal women. Multiple clinical trials and systematic reviews demonstrate that low-dose testosterone, kept within the physiologic female range, does not increase serious adverse events in the short to medium term.
Cardiovascular safety: Short-term studies of up to 24 months show no clear increase in cardiovascular events when testosterone is maintained at female levels. This is reassuring, though long-term data beyond two years are still limited.
Breast cancer risk: Current evidence shows no clear increase in breast cancer risk when testosterone levels are kept in the physiologic female range for up to two years. Women with active hormone-sensitive cancers should avoid testosterone or use it only under specialist guidance.
Metabolic effects: Transdermal testosterone has not shown the adverse lipid effects seen with some oral formulations. When properly dosed, it doesn't negatively impact cholesterol profiles.
When testosterone is prescribed for women, the goal is physiologic replacement, restoring levels to the range typical for healthy premenopausal women. Benefits seen in clinical studies come from low doses, not from pushing testosterone above that range. Increasing the dose beyond physiologic levels has not been shown to improve sexual desire further, but it does increase the likelihood of androgen-related side effects.
Those side effects are dose-dependent and can include acne, oily skin, increased facial or body hair, scalp hair thinning, and voice changes. Some changes, particularly voice deepening, may not fully reverse if testosterone levels remain too high. This is why careful dosing and regular monitoring matter more than achieving a specific number or rapid effect.
Some women describe feeling “amazing” when testosterone levels are pushed higher at first: often reporting a short-term boost in energy, confidence, or libido. These effects are frequently temporary. As the body adapts, benefits may fade while side effects become more noticeable, leading to repeated dose escalation instead of reassessment. If a physiologic dose hasn’t helped after an appropriate trial, increasing the dose is unlikely to change that, and it may create new problems rather than lasting improvement.
When testosterone is properly dosed for women, serious side effects are uncommon. The problems arise with overdosing:
Common signs of excess testosterone (generally reversible):
Serious virilizing effects (rare at appropriate doses, may be irreversible):
Here's where honesty matters: we don't have robust long-term safety data beyond 24 months. Most clinical trials evaluating testosterone in women have been relatively short term. This doesn't mean testosterone is unsafe long term, it means we're still learning.
For women considering testosterone therapy for menopause, this means:
Certain situations make testosterone therapy inappropriate or higher risk:
Generally should not use testosterone:
Requires very careful risk-benefit analysis:
The critical factor in safety is proper dosing and monitoring. When women take testosterone at doses appropriate for female physiology (not male-range "optimization" levels) and work with experienced providers who monitor regularly, serious risks are low.
If testosterone is appropriate for your menopause symptoms, how you take it determines your safety profile.
Transdermal testosterone (gel or cream) is the safest option for menopausal women because it:
Doses for women are approximately one-tenth of male doses, typically applied daily.
Testosterone pellets carry higher safety risks:
Injections cause hormone level fluctuations, peaks and valleys that may increase side effect risk and make dosing harder to optimize.
Oral testosterone poses liver metabolism concerns and adverse cholesterol effects not seen with transdermal forms.
Safety isn't just about choosing the right formulation, it's about ongoing surveillance. Recent 2026 guidelines emphasize monitoring as essential to safe testosterone use:
Before starting:
Early follow-up (3-6 weeks):
Ongoing (every 4-6 months once stable):
The safety principle: If testosterone isn't helping by 6 months, guidelines recommend stopping. There's no reason to accept potential risks without demonstrated benefit.
The goal is maintaining testosterone in the physiologic female range, the levels healthy premenopausal women have. This is not "optimized" levels, high-normal male levels, or supraphysiologic levels.
Some clinics market higher doses promising better results. This is where safety gets compromised. The evidence for benefit is at physiologic female levels. Going higher increases risk without proven additional benefit.
One of the most common questions women ask: "Should I try supplements before hormone therapy?" or "Can supplements fix my hormone levels naturally?"
The short answer: supplements can support general health and may help with mild symptoms, but they typically cannot address true hormone deficiencies that cause significant menopause symptoms.
Understanding this distinction is crucial for making informed decisions about your health.
When you're experiencing genuine hormone deficiency, your body lacks adequate amounts of that specific hormone. Supplements don't contain bioidentical estrogen or testosterone. They may contain:
The limitation: These approaches may help with mild symptoms or support your body's own hormone production at the margins, but they cannot replicate the physiologic effects of actual hormone replacement when you have significant deficiency.
Think of it this way: If you have type 1 diabetes and your pancreas produces no insulin, taking supplements to "support pancreatic health" won't fix the problem. You need insulin. Similarly, if your ovaries are producing very little estrogen after menopause and you have severe symptoms, taking supplements to "support hormone balance" typically won't provide the relief that estrogen therapy can.
Supplements aren't useless, they just have a different role:
Supplements can be appropriate for:
Examples of supplements with some evidence for menopause:
The reality: These supplements may reduce symptom severity by 10-30% in some women. Estrogen therapy typically reduces hot flashes by 70-90%. That's the difference between supporting your body and replacing what's missing.
Many women are drawn to supplements because they seem "more natural" than hormone therapy. But consider:
The question shouldn't be "natural vs. synthetic" but rather "What has evidence for safety and effectiveness for my specific symptoms?"
You'll see supplements marketed as "testosterone boosters" or products claiming to "naturally increase testosterone." For menopausal women with HSDD:
These supplements do not work like testosterone therapy:
If you have genuine HSDD, you need actual testosterone at appropriate doses with monitoring—not supplements hoping to slightly nudge your body's production.
Consider hormone therapy instead of or in addition to supplements if:
The advantage of hormone therapy: You can measure levels, adjust doses precisely, and track whether the treatment is working. With supplements, you're largely guessing.
For many women, the optimal approach isn't "hormone therapy vs. supplements" but rather understanding what each can and can't do:
Good general approach:
For testosterone specifically:
Be cautious of supplements marketed as "hormone balancing" solutions. This language is often vague and unsupported. Your hormones don't need to be "balanced", they change naturally through life stages. What matters is whether you have symptoms caused by deficiency that would benefit from proven treatments.
Marketing that promises supplements will "balance hormones" and eliminate all menopause symptoms is misleading. It may delay you from getting effective treatment and can be expensive without delivering meaningful results.
Testosterone does not replace estrogen therapy for menopause. For classic menopause symptoms, estrogen remains the first-line, most effective treatment. If you still have your uterus, you need progesterone along with estrogen for uterine protection. Testosterone doesn't provide this.
When testosterone is appropriate for menopause, it's add-on therapy for sexual desire concerns, not primary menopause treatment. Many menopausal women do well on estrogen alone, some benefit from estrogen plus progesterone, and a smaller subset find that adding testosterone addresses persistent libido concerns that estrogen didn't fully resolve.
Understanding this helps you advocate for comprehensive menopause care rather than single-hormone solutions.
Can women take testosterone for menopause safely? Yes, when it's used correctly.
The evidence from the past several years, including recent 2026 guidelines, shows that testosterone therapy is safe for carefully selected menopausal women when:
Short-term safety data (up to 2 years) are reassuring. Long-term data are still evolving, which means ongoing discussions with your provider about risk-benefit balance as you continue therapy.
Testosterone therapy for menopause might be right for you if:
This is one of the top questions because weight gain and body composition changes are extremely common menopause concerns. Women often hear claims about testosterone improving metabolism and muscle mass, leading them to ask if it's the solution to menopause weight struggles.
Why it's asked so often: Social media and wellness clinics heavily market testosterone for body composition benefits, creating expectations that don't match the evidence.
Women are frequently confused about "bioidentical" marketing and whether it's safer or more effective than conventional hormone therapy.
Why it's asked so often: The term "bioidentical" is used extensively in marketing and sounds more natural/safer, but many women don't understand it just refers to molecular structure, not necessarily to compounded vs. FDA-approved products.
Crushing fatigue is one of the most distressing menopause symptoms, and women desperately want solutions. Testosterone is often presented as an energy booster.
Why it's asked so often: Fatigue is ubiquitous in menopause, and when estrogen therapy doesn't fully resolve it, women look for additional solutions. Many practitioners suggest testosterone for this off-label use.
Women want to understand if testing will reveal whether they "need" testosterone, and they're often confused about whether low numbers alone justify treatment.
Why it's asked so often: There's confusion about whether testosterone therapy is based on symptoms vs. lab values, and many women have been told by practitioners that their levels are "low" without context about whether treatment is appropriate.
This encompasses fears about side effects like facial hair, deep voice, or other virilizing effects—essentially, will testosterone make them lose their feminine characteristics?
Why it's asked so often: This is the most visceral fear women have about testosterone therapy, fueled by seeing these effects in athletes or bodybuilders using much higher doses. Women need reassurance about what appropriate dosing means for feminization concerns.
Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G. D., Hirschberg, A. L., Rodenberg, C., Pack, S., Koch, H., Moufarège, A., & Studd, J. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal of Medicine, 359(19), 2005-2017. https://doi.org/10.1056/nejmoa0707302
Islam, R. M., Bell, R. J., Green, S., Page, M. J., & Davis, S. R. (2019). Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Fertility and Sterility, 111(4), 754-766. https://doi.org/10.1016/j.fertnstert.2019.01.014
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., Parish, S. J., Pinkerton, J., Rymer, J., Simon, J. A., Vignozzi, L., & Wierman, M. E. (2019). Global Consensus Position Statement on the use of testosterone therapy for women. Journal of Clinical Endocrinology & Metabolism, 105(3), e42-e52. https://doi.org/10.1210/clinem/dgz137
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., Park, K., Stuenkel, C. A., Traish, A. M., & Vignozzi, L. (2021). International Society for the Study of Women's Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. Sexual Medicine Reviews, 9(3), 393-415. https://doi.org/10.1016/j.sxmr.2020.10.009
Goldstein, I., Kim, N. N., Clayton, A. H., DeRogatis, L. R., Giraldi, A., Parish, S. J., Pfaus, J., Simon, J. A., Kingsberg, S. A., Meston, C., Stahl, S. M., Wallen, K., & Worsley, R. (2024). Hypoactive sexual desire disorder: International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review and recommendations. Sexual Medicine Reviews, 12(2), 101-125. https://doi.org/10.1093/sxmrev/qeae001